Stevanato Group Spa
STVN
Market Cap$5.17B
Close$
$-19.13
181.5% downside
Current Fair Value
181.5% downsideOvervalued by 181.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.17 Billion |
|---|---|
| Enterprise Value | $5.55 Billion |
| Dividend Yield | $0.06 (0.305745914602003%) |
| Earnings per Share | $0.54 |
| Beta | 0.58 |
| Outstanding Shares | 272,789,169 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 38.48 |
|---|---|
| PEG | 93.99 |
| Price to Sales | 5.87 |
| Price to Book Ratio | 4.7 |
| Enterprise Value to Revenue | 4.93 |
| Enterprise Value to EBIT | 28.27 |
| Enterprise Value to Net Income | 44 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Stevanato Group Spa
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end por...